APPROVED PACKAGE INSERT FOR INGELVAC MYCOFLEX

Size: px
Start display at page:

Download "APPROVED PACKAGE INSERT FOR INGELVAC MYCOFLEX"

Transcription

1 APPROVED PACKAGE INSERT FOR INGELVAC MYCOFLEX Only for use by or under the supervision of persons registered in terms of or authorised in terms of section 23 (1) (c) of the Veterinary and Para-Veterinary Professions Act, (Act No. 19 of 1982) FOR ANIMAL USE ONLY Ingelvac MycoFLEX Vaccine (Reg. No. G3933 Act 36/1947) Namibian reg. no.: V11/24.3/1018 (Act 13/2003) Dosage form: Suspension for injection. Storage Instructions: Keep out of reach and sight of children. Store and transport refrigerated (2-8 C). Do not freeze. Protect from light. Do not use after the expiry date (EXP) stated on the carton and bottle. Use immediately after opening.

2 Composition: Inactivated Mycoplasma hyopneumoniae, strain J, isolate B-3745 Each dose of 1 ml inactivated vaccine contains: Mycoplasma hyopneumoniae Minimum RP* 1.0, Maximum RP* 4.61 *Relative potency (ELISA test) when compared to a reference vaccine. Adjuvant: Carbomer. Target species: Pigs. Indications: For active immunisation of pigs from 3 weeks of age to reduce lung lesions following infection with Mycoplasma hyopneumoniae. Onset of immunity: by 2 weeks post vaccination. Duration of immunity: at least 26 weeks

3 Adverse reactions: Adverse reactions are uncommon: transient swelling up to 4 centimetres in diameter, sometimes associated with redness of the skin, may sometimes be observed at the injection site. These swellings may last up to 5 days. A transient mean increase in rectal body temperature of about 0.8 C lasting up to 20 hours after vaccination may be observed. If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. Warnings: Keep out of reach of children, uninformed persons and animals. Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder. In case of accidental self injection, seek medical advice immediately and show the package leaflet or label to the medical doctor. Destroy any unused vaccine by for example burning; dispose of all the vaccine containers once the vaccination is completed Withdrawal period: 21 days.

4 Precautions for use: Ingelvac MycoFLEX can be mixed aseptically with Ingelvac CircoFLEX and administered together. Apart from the combined use with Ingelvac CircoFLEX, no information is available on the safety and efficacy of the combined use of Ingelvac MycoFLEX with any other veterinary medicinal product. Vaccinate only clinically healthy animals. In case of anaphylactic reactions, the administration of epinephrine (adrenaline) is recommended. Directions for use use only as directed: Shake well before use. Avoid introduction of contamination during use. Avoid multiple broaching from bottle. Vaccination devices should be used in accordance with the device instructions provided by the manufacturer. Use equipment that prevents backflow of the veterinary medicinal product. Dosage for administration: Single use of Ingelvac MycoFLEX only: Single intramuscular injection of one dose (1 ml) preferably in the neck of pigs three weeks of age and older.

5 Combined use with Ingelvac CircoFLEX : Shake each bottle before use. Aseptically mix the full contents of each bottle. Shake well. Inject a single 2 ml dose intramuscularly. Effects of the vaccine: Immunological properties: The vaccine is designed to stimulate the development of an active immune response to Mycoplasma hyopneumoniae. Presentation: *Bottle of 10 ml (10 dose), 50 ml (50 dose), 100 ml (100 dose) or 250 ml (250 dose). Not all pack sizes may be marketed. *The vaccine is available in either conventional capacity bottles or larger headspace bottles. These larger size bottles with more space above the suspension facilitate the convenient mixing of the Ingelvac MycoFLEX and Ingelvac CircoFLEX vaccines together. Registration holder: Ingelheim Pharmaceuticals (Pty) Ltd (Reg. No. 1966/008618/07) 407 Pine Avenue Randburg South Africa 2125 Tel No.: + 27 (0)

6 Voubiljet vir Ingelvac MycoFLEX (Afrikaans) Slegs vir gebruik deur of onder die toesig van persone geregistreer in gevolge van of wat magtiging ontvang het in gevolge seksie 23 (1) (c) van die Veterinêre en Para-Veterinêre Professies Wet, (Wet Nr. 19 van 1982). SLEGS VIR DIEREGEBRUIK: Ingelvac MycoFLEX Entstof (Reg. Nr. G3933 Wet 36/1947) Doseringsvorm: Suspensie vir inspuiting. Bergingsaanwysings: Hou buite bereik en sig van kinders. Bewaar en vervoer tussen + 2 C en + 8 C. Moenie vries nie. Beskerm teen lig. Moet nie gebruik na die vervaldatum (EXP) soos aangetoon op die kartonhouer en botteletiket nie.

7 Gebruik onmiddellik na oopgemaak. Samestelling: Geïnaktiveerde Mycoplasma hyopneumoniae, stam J, isolaat B-3745 Elke 1 ml geïnaktiveerde entstof bevat Mycoplasma hyopneumoniae Minimum RS* 1.0, Maksimum RS* * Relatiewe sterkte (ELISA toets) vergeleke met n verwysingsentstof. Adjuvant: Karbomeer. Teikenspesie: Varke. Aanbevelings vir gebruik: Vir die aktiewe enting van varke, drie weke of ouer, om long letsels na infeksie met Mycoplasma hyopneumoniae, te verminder. Aanvang van immuniteit: teen 2 weke na inenting Duur van immuniteit: ten minste 26 weke. Newe-effekte: Newe-effekte kom nie dikwels voor nie: Daar kan soms by die inspuitplek n verbygaande swelsel, tot 4 cm in deurnsee, soms tesame met n rooi velverkleuring, waargeneem word. Hierdie swelsels kan tot 5 dae duur. Daar kan n verbygaande gemiddelde verhoging in rektale liggaamstemperatuur van ongeveer 0.8 C, wat tot 20 ure na enting kan duur, waargeneem word.

8 Stel jou veearts in kennis indien jy enige ernstige newe-effekte, of enige ander effekte nie genoem in hierdie voubiljet nie, waarneem. Waarskuwings: Hou buite bereik van kinders, oningeligte persone en diere. Hoewel die middel omvattend onder n groot verskeidenheid van toestande getoets is, mag dit om verskeie redes faal. As dit vermoed word, raadpleeg ʼn veearts en verwittig die registrasiehouer. In geval van toevallige selfinspuiting, kry dadelik mediese advies en wys die voubiljet of etiket vir die geneesheer. Onttrekkingstydperk: 21 dae. Voorsorgmaatreëls vir gebruik: Ingelvac MycoFLEX kan asepties vermeng word met Ingelvac CircoFLEX en saam toegedien word. Afgesien van die gesamentlike toediening met Ingelvac CircoFLEX, is daar is geen inligting beskikbaar oor die veiligheid en doeltreffendheid van die gesamentlike gebruik van hierdie entstof met enige ander veterinêre medisinale produk nie. Enige ongebruikte entstof en alle entstof houers moet na inenting weggegooi word. Ent slegs klinies gesonde diere. Indien anafilaktoïede reaksies voorkom word die toediening van epinefrien (adrenalien) aanbeveel.

9 Aanwysings vir gebruik gebruik slegs soos aangedui: Skud goed voor gebruik. Voorkom kontaminasie tydens gebruik. Vermy veelvuldige onttrekkings uit bottel. Entingstoestelle moet in ooreenstemming met die gebruiksaanwysings, soos aanbeveel deur die vervaardiger, aangewend word. Gebruik apparaat wat die terugvloei van die veterinêre medisinale produk voorkom. Dosis vir toediening: Enkel toediening van Ingelvac MycoFLEX : Dien n enkele 1 ml dosis binnespiers (verkieslik in die nek) toe aan varke drie weke of ouer. Gekombineerde toediening met Ingelvac CircoFLEX : Skud elke bottel voor gebruik. Meng asepties die volle inhoud van elke bottel. Skud goed. Dien n enkele 2 ml dosis binnespiers toe. Effekte van die entstof: Immunologiese eienskappe: Die entstof is ontwerp om die ontwikkeling van n aktiewe immuunreaksie teen Mycoplasma hyopneumoniae te stimuleer.

10 Aanbieding: * Bottel met 10 ml (10 dosisse), 50 ml (50 dosisse), 100 ml (100 dosisse) of 250 ml (250 dosisse). Nie alle verpakkingsgroottes word noodwendig bemark nie. * Die entstof is beskikbaar in óf konvensionele kapasiteit bottels óf die groter headspace bottels. Die groter bottels met meer spasie bo die suspensie fasiliteer gerieflik die gelyktydige vermenging van die Ingelvac MycoFLEX en Ingelvac CircoFLEX entstowwe. Registrasiehouer: Ingelheim Pharmaceuticals (Edms) Bpk (Reg. Nr. 1966/008618/07) Pinelaan 407 Randburg 2125 Tel nr (0)

FOR ANIMAL USE ONLY. BERENIL R.T.U. Reg. No. G2702 (Act 36/1947) Namibia Reg. No. V00/17.4.2/638 NS0

FOR ANIMAL USE ONLY. BERENIL R.T.U. Reg. No. G2702 (Act 36/1947) Namibia Reg. No. V00/17.4.2/638 NS0 FOR ANIMAL USE ONLY BERENIL R.T.U. Reg. No. G2702 (Act 36/1947) Namibia Reg. No. V00/17.4.2/638 NS0 INDICATIONS Berenil R.T.U. cures and prevents Redwater in cattle and cures biliary fever in dogs and

More information

Package insert for Enterisol Ileitis (English)

Package insert for Enterisol Ileitis (English) FOR ANIMAL USE ONLY Package insert for Enterisol Ileitis (English) Enterisol Ileitis abcd Vaccine (Reg. No. G3743 Act 36/1947) NAMIBIA: V10/24.5/878 (ACT 13 OF 2003) Dosage form: Lyophilisate and diluent

More information

KYNOBUFF IN CASE OF POISONING PLEASE PHONE / IN GEVAL VAN VERGIFTIGING SKAKEL l Netto Volume

KYNOBUFF IN CASE OF POISONING PLEASE PHONE / IN GEVAL VAN VERGIFTIGING SKAKEL l Netto Volume KYNOBUFF Reg. No.L4246, Act No./Wet Nr. 36 of/van 1947 A ph buffer for increasing the efficiency of ph sensitive agricultural remedies and improving the wetting and spreading properties of spray mixtures.

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ingelvac CircoFLEX suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose (1 ml)

More information

A water-soluble foliar feed with a wide range of nutrients for plants. n Wateroplosbare blaarvoeding met n wye reeks voedingselemente vir plante.

A water-soluble foliar feed with a wide range of nutrients for plants. n Wateroplosbare blaarvoeding met n wye reeks voedingselemente vir plante. FERTILIZER GROUP / MISSTOF GROEP II Reg. No. K 7652 Act/Wet 36 of/van 1947 1: 08/02/07 Oct 2013 Feed-P 2.1.2 (44) A water-soluble foliar feed with a wide range of nutrients for plants. n Wateroplosbare

More information

VERTE-X-PLODE Reg. No. B 3602 Act/Wet No. 36 of/van 1947

VERTE-X-PLODE Reg. No. B 3602 Act/Wet No. 36 of/van 1947 VERTE-X-PLODE Reg. No. B 3602 Act/Wet No. 36 of/van 1947 ACTIVE INGREDIENTS / AKTIEWE BESTANDDELE: K.51.3 g/kg P.40.7 g/kg Mo..41 mg/kg B.360 mg/kg Chelated / Cheleerd Fe.3942 mg/kg Mn.1440 mg/kg Zn..990

More information

F U N G I N E X. Active Ingredient / Aktiewe Bestanddeel. Triforine g/l...triforien

F U N G I N E X. Active Ingredient / Aktiewe Bestanddeel. Triforine g/l...triforien F U N G I N E X REG. NO. L 2469 / N-AR 0131 ACT NO 36 of 1947 W 130281 AN EMULSIFIABLE CONCENTRATE 'N EMULGEERBARE KONSENTRAAT SYSTEMIC FUNGICIDE FOR THE SISTEMIESE SWAMDODER VIR DIE CONTROL OF POWDERY

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn M.hyo - Parasuis, suspension for injection for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: per 2 ml dose Inactivated Mycoplasma

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn PCV suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 2 ml contains:

More information

NEOPYBUTHRIN. REG. NO. L4582 Act No. 36 of 1947 REG. NR. L4582 Wet Nr. 36 van 1947 Namibian Reg. No. N-AR 0592 Nambiese Reg. Nr.

NEOPYBUTHRIN. REG. NO. L4582 Act No. 36 of 1947 REG. NR. L4582 Wet Nr. 36 van 1947 Namibian Reg. No. N-AR 0592 Nambiese Reg. Nr. NEOPYBUTHRIN REG. NO. L4582 Act No. 36 of 1947 REG. NR. L4582 Wet Nr. 36 van 1947 Namibian Reg. No. N-AR 0592 Nambiese Reg. Nr. N-AR 0592 MISTING AND FOGGING SOLUTION FOR THE CONTROL OF COCKROACHES, HOUSE

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:

More information

BOND. Reg. No./Reg. Nr. L6756, Act No. 36 of 1947/Wet Nr. 36 van 1947

BOND. Reg. No./Reg. Nr. L6756, Act No. 36 of 1947/Wet Nr. 36 van 1947 Sales Panel For further information see attached pamphlet Vir verdere inligting sien aangehegte pamflet Reg. No./Reg. Nr. L6756, Act No. 36 of 1947/Wet Nr. 36 van 1947 CONTAINS A STICKER AND A NON-IONIC

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV M Hyo emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 2 ml contains: Active

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BIOCOM P Vet, suspension for injection for minks (all MS except DK) BIOVAC-BP, suspension for injection for minks (DK) 2.

More information

PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET

PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET BIOVETA, a. s. Komenského 212, 683 23 Ivanovice na Hané, Czech Republic, e-mail: obchod@bioveta.cz PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET SUMMARY OF PRODUCT CHARACTERISTICS

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RESPIPORC FLUpan H1N1 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of

More information

Cambridge International Examinations Cambridge International General Certificate of Secondary Education

Cambridge International Examinations Cambridge International General Certificate of Secondary Education Cambridge International Examinations Cambridge International General Certificate of Secondary Education *8496711001* AFRIKAANS AS A SECOND LANGUAGE 0548/05 Paper 5 Oral Assessment A October/November 2017

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Versifel FeLV, suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:

More information

ACTIVE INGREDIENT / AKTIEWE BESTANDDEEL: Brodifacoum (Anticoagulant) /Brodifakoum (Bloedstolweermiddel)..0,75 g / 500 m ; 1 Litre

ACTIVE INGREDIENT / AKTIEWE BESTANDDEEL: Brodifacoum (Anticoagulant) /Brodifakoum (Bloedstolweermiddel)..0,75 g / 500 m ; 1 Litre MAIN PANEL RODEX LIQUID BAIT Reg. No./Nr.: L9289 Act /Wet 36 /1947 A highly active anticoagulant liquid bait concentrate for the control of the Norway Rat (Rattus norwegicus), Roof Rat (Rattus rattus),

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Proteq West Nile suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Respiporc FLU3 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ProteqFlu suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 1 ml contains:

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval 3 BRSV Pi3 BVD Lyophilisate and suspension for suspension for injection for cattle 2. QUALITATIVE AND QUANTITATIVE

More information

NIMROD. Reg. no. L1117 Act/Wet 36 of/van 1947 FRAC FUNGICIDE GROUP CODE 8 FRAC SWAMDODERGROEPKODE ACTIVE INGREDIENT/AKTIEWE BESTANDDEEL

NIMROD. Reg. no. L1117 Act/Wet 36 of/van 1947 FRAC FUNGICIDE GROUP CODE 8 FRAC SWAMDODERGROEPKODE ACTIVE INGREDIENT/AKTIEWE BESTANDDEEL NIMROD Reg. no. L1117 Act/Wet 36 of/van 1947 An emulsifiable concentrate systemic fungicide for the control of powdery mildew in apples, peaches, cucurbits and mangoes. 'n Emulgeerbare konsentraat sistemiese

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis OR inac emulsion for injection for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 0.25

More information

INDICATIONS: For the relief of mild to moderate pain and fever such as headaches, toothache and pain associated with colds and flu.

INDICATIONS: For the relief of mild to moderate pain and fever such as headaches, toothache and pain associated with colds and flu. SCHEDULING STATUS: S0 PROPRIETARY NAME: (AND DOSAGE FORM) PANADO EFFERVESCENT (TABLETS) COMPOSITION: Each tablet contains: 500 mg paracetamol. Sugar free. PHARMACOLOGICAL CLASSIFICATION: A 2.7 Antipyretic

More information

Before using this product read the label carefully. / Lees die etiket noukeurig alvorens die produk gebruik word. PYBUTHRIN 44

Before using this product read the label carefully. / Lees die etiket noukeurig alvorens die produk gebruik word. PYBUTHRIN 44 Before using this product read the label carefully. / Lees die etiket noukeurig alvorens die produk gebruik word. PYBUTHRIN 44 Reg. No. L4629 Act No. 36 of 1947 Reg. Nr. L4629 Wet Nr. 36 van 1947 Namibian

More information

Reg. no. L7459 Act/Wet 36 of/van 1947 FRAC FUNGICIDE GROUP CODE M7 FRAC SWAMDODERGROEPKODE ACTIVE INGREDIENT/AKTIEWE BESTANDDEEL

Reg. no. L7459 Act/Wet 36 of/van 1947 FRAC FUNGICIDE GROUP CODE M7 FRAC SWAMDODERGROEPKODE ACTIVE INGREDIENT/AKTIEWE BESTANDDEEL KENOPEL 200 SL Reg. no. L7459 Act/Wet 36 of/van 1947 A water soluble concentrate contact fungicide for the control of post-harvest decay (green and blue moulds and sour rot) in citrus. n Wateroplosbare

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis Pesti emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml

More information

Although this remedy has been extensively tested under a large variety of conditions the registration holder does not

Although this remedy has been extensively tested under a large variety of conditions the registration holder does not WARNINGS: THE FOLLOWING NUMBER OF DAYS MUST BE ALLOWED BETWEEN LAST APPLICATION AND HARVEST: Potatoes... 14 days Apples and Pears... 30 days Cruciferae... 3 days Peaches... 28 days Plums... 28 days Tobacco...

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BTVPUR suspension for injection for sheep and cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ProteqFlu-Te Suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose contains:

More information

QA Amendment Sugar and layout 09/03/2007

QA Amendment Sugar and layout 09/03/2007 SCHEDULING STATUS: S0 QA Amendment PROPRIETARY NAME: (and dosage form) PANADO INFANT DROPS (Drops) COMPOSITION: Each 0,6 ml contains: Paracetamol Preservatives: Methylparaben Propylparaben 60 mg 0,085%

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis Influenza H5N2 emulsion for injection for chickens. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Circovac emulsion and suspension for emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AFTOVAXPUR DOE emulsion for injection for cattle, sheep and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax Rabies suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:

More information

PY 4T4. Reg. No. L4629 Act No. 36 of 1947 Reg. Nr. L4629 Wet Nr. 36 van 1947 Namibian Reg. No. N-AR 0585 Namibiese Reg. Nr.

PY 4T4. Reg. No. L4629 Act No. 36 of 1947 Reg. Nr. L4629 Wet Nr. 36 van 1947 Namibian Reg. No. N-AR 0585 Namibiese Reg. Nr. PY 4T4 Reg. No. L4629 Act No. 36 of 1947 Reg. Nr. L4629 Wet Nr. 36 van 1947 Namibian Reg. No. N-AR 0585 Namibiese Reg. Nr. N-AR 0585 A FOGGING OR MISTING SPRAY INSECTICIDE FOR THE CONTROL OF CRAWLING AND

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Bovela lyophilisate and solvent for suspension for injection for cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Part I.B page 1 of 7 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/7 Part I.B page 2 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Ducat (DE: Nobivac RC, SE : Nobivac Ducat vet.) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Per

More information

Bovine Herpes Virus type 1 (BoHV-1), strain Difivac (ge-negative), to induce a geometric mean seroneutralizing titre of at least 1:160 in cattle

Bovine Herpes Virus type 1 (BoHV-1), strain Difivac (ge-negative), to induce a geometric mean seroneutralizing titre of at least 1:160 in cattle 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval IBR-Marker Inactivated 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One dose (2ml) contains Active Substance: Bovine Herpes Virus type 1 (BoHV-1), strain

More information

The evaluation of a new haematological cell counter, the CELL-DYN 3500, on canine leukocyte differential counts

The evaluation of a new haematological cell counter, the CELL-DYN 3500, on canine leukocyte differential counts The evaluation of a new haematological cell counter, the CELL-DYN 3500, on canine leukocyte differential counts by T Prinsloo Submitted to the Faculty of Veterinary Science, University ofpretoria, in partial

More information

Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1

Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1 Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1 PACKAGE LEAFLET Rispoval IBR-Marker Vivum Lyophilisate and diluent for suspension for injection for cattle. 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per

More information

Rotavec Corona Emulsion for injection for cattle. Introduction. Company name: MSD Animal Health. Address: Walton Manor. Walton. Milton Keynes MK7 7AJ

Rotavec Corona Emulsion for injection for cattle. Introduction. Company name: MSD Animal Health. Address: Walton Manor. Walton. Milton Keynes MK7 7AJ Rotavec Corona Emulsion for injection for cattle Introduction Company name: MSD Animal Health Address: Walton Manor Walton Milton Keynes MK7 7AJ Telephone: 01908 685685 (Customer Support Centre) Fax: 01908

More information

Reg. No./Nr. L 6311, Act No. /Wet Nr. 36 of /van 1947

Reg. No./Nr. L 6311, Act No. /Wet Nr. 36 of /van 1947 For further information see attached pamphlet Vir verdere inligting sien aangehegte pamflet Isomate -C Plus Reg. No./Nr. L 6311, Act No. /Wet Nr. 36 of /van 1947 A synthetic mating disruption pheromone

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Versifel FeLV, suspension for injection for cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains: Active substance: Inactivated feline leukaemia

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Piro lyophilisate and solvent for suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac L4 suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT VANGUARD CPV-L 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Quantity per 1 ml dose Active substance(s): Live attenuated canine Parvovirus, strain NL-35-D, low passage,

More information

B. PACKAGE LEAFLET 1

B. PACKAGE LEAFLET 1 B. PACKAGE LEAFLET 1 PACKAGE LEAFLET BioEquin H, emulsion for injection for horses 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican DAPPi lyophilisate and solvent for suspension for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac L4, suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Equip WNV emulsion for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:

More information

FERTIFLO (19) MICRONUTRIENT SOLUTION

FERTIFLO (19) MICRONUTRIENT SOLUTION FERTIFLO 3-2-1 (19) MICRONUTRIENT SOLUTION FERTILIZER GROUP 1 A liquid fertilizer for foliar feeding and fertigation. FERTIFLO 3-2-1 (19) is a liquid fertilizer containing sulphur and the essential range

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ERYSENG PARVO suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP FeLV lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Equilis Prequenza suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of

More information

Paul-Ehrlich-Institut

Paul-Ehrlich-Institut Paul-Ehrlich-Institut DE/V/0021/001/II/014 Page 1 Paul-Ehrlich-Institut Federal Institute for Vaccines and Biomedicines FINALISATION REPORT ON VARIATION TYPE II PRODUCT DETAILS Name of products Active

More information

APPROVED PACKAGE INSERT

APPROVED PACKAGE INSERT SCHEDULING STATUS S4 APPROVED PACKAGE INSERT PROPRIETARY NAME AND DOSAGE FORM SIMPONI Solution for Injection COMPOSITION Each 0,5 ml single use pre-filled syringe or pre-filled pen contains 50 mg of golimumab.

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ZULVAC 8 Ovis suspension for injection for sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 2 ml of

More information

*Gebaseer op die Nasionale Kanker Register Leeftyd risiko vir prostaatkanker 1:27. testikulêrekanker 1: peniskanker 1:1 114

*Gebaseer op die Nasionale Kanker Register Leeftyd risiko vir prostaatkanker 1:27. testikulêrekanker 1: peniskanker 1:1 114 *Gebaseer op die Nasionale Kanker Register 2010 Leeftyd risiko vir prostaatkanker 1:27 Leeftyd risiko vir testikulêrekanker Leeftyd risiko vir peniskanker 1:2 040 1:1 114 Prostaatkanker 1 uit 27 Suid-Afrikaanse

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RHINISENG suspension for injection for pigs. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Myxo-RHD lyophilisate and solvent for suspension for injection for rabbits 2. QUALITATIVE AND QUANTITATIVE

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Equilis StrepE, lyophilisate and solvent for suspension for injection, for horses 2. QUALITATIVE AND QUANTITATIVE

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MS-H Vaccine eye drops suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: One dose (30 µl)

More information

STRESBELEWING BY LEERDERS MET LEERINPERKINGE IN DIE INTERMEDIÊREFASE. deur MJ VAN BREDA

STRESBELEWING BY LEERDERS MET LEERINPERKINGE IN DIE INTERMEDIÊREFASE. deur MJ VAN BREDA STRESBELEWING BY LEERDERS MET LEERINPERKINGE IN DIE INTERMEDIÊREFASE deur MJ VAN BREDA STRESBELEWING BY LEERDERS MET LEERINPERKINGE IN DIE INTERMEDIÊREFASE deur MAYNARD JOHN VAN BREDA voorgelê ter gedeeltelike

More information

1. NAME OF THE VETERINARY MEDICINAL PRODUCT. ALPHA JECT micro 6 emulsion for injection for Atlantic salmon 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

1. NAME OF THE VETERINARY MEDICINAL PRODUCT. ALPHA JECT micro 6 emulsion for injection for Atlantic salmon 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ALPHA JECT micro 6 emulsion for injection for Atlantic salmon 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance(s): 1 dose (0.05 ml) contains: Formaldehyde

More information

MUSIEK - VOKAAL. 17 Augustus 20 Augustus Voorsitter: Lorraine Kirk

MUSIEK - VOKAAL. 17 Augustus 20 Augustus Voorsitter: Lorraine Kirk MUSIEK - VOKAAL 17 Augustus 20 Augustus 2015 Voorsitter: Lorraine Kirk - 082 689 2707 lorrainekirk58@gmail.com Die algemene reëls moet saam met die spesifieke reëls gelees word INSKRYWINGSFOOIE Solo R

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Coliprotec F4/F18 lyophilisate for oral suspension for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose

More information

STOMAWET. Reg. No. L6692, Act No. / Wet Nr. 36 of /van 1947 A NON-IONIC ORGANOSILICONE ADJUVANT FOR USE WITH CROP PROTECTION REMEDIES AS INDICATED.

STOMAWET. Reg. No. L6692, Act No. / Wet Nr. 36 of /van 1947 A NON-IONIC ORGANOSILICONE ADJUVANT FOR USE WITH CROP PROTECTION REMEDIES AS INDICATED. Sales PANEL For further information see attached pamphlet Vir verdere inligting sien aangehegte pamflet STOMAWET Reg. No. L6692, Act No. / Wet Nr. 36 of /van 1947 A NON-IONIC ORGANOSILICONE ADJUVANT FOR

More information

Rift Valley fever is a fever-causing viral disease that affects livestock and humans in Africa. It is most common during years of heavy rainfall.

Rift Valley fever is a fever-causing viral disease that affects livestock and humans in Africa. It is most common during years of heavy rainfall. Slenkdalkoors Slenkdalkoors is n erge insekgedraagde virussiekte wat hoefdiere soos skape, bokke en beeste aantas. Dit hou ook n ernstige gesondheidsgevaar vir die mens in. Diere word aanvanklik besmet

More information

Package Insert. Other excipients include: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium,

Package Insert. Other excipients include: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, Package Insert SCHEDULING STATUS Schedule 4 PROPIETARY NAME & DOSAGE FORM ZYTIGA 250 mg tablets COMPOSITION Each tablet contains 250 mg of abiraterone acetate. Other excipients include: lactose monohydrate,

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BioEquin H, emulsion for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One vaccine dose (1 ml) contains:

More information

Submitted: 19 February 2015 Reference: RA/2016/02/031cp Amendment type: Response to DHCP letter and compliant response to CCC dated 02 December 2014

Submitted: 19 February 2015 Reference: RA/2016/02/031cp Amendment type: Response to DHCP letter and compliant response to CCC dated 02 December 2014 PACKAGE INSERT SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM MOTILIUM 1 mg/ml suspension COMPOSITION Each ml contains 1 mg domperidone, with 0,18 % m/v methylparaben and 0,02 % m/v propylparaben

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval IBR-Marker Vivum, Lyophilisate and diluent for suspension for injection for cattle Rispoval IBR-Marker Live (for

More information

GALACTICA. Reg. No.: L 9286 Act /Wet No. 36 of/van 1947

GALACTICA. Reg. No.: L 9286 Act /Wet No. 36 of/van 1947 GALACTICA Reg. No.: L 9286 Act /Wet No. 36 of/van 1947 A systemic fungicide as an emulsion, oil in water for the control of scab in apples and pears and powdery mildew in apples. n Sistemiese swamdoder

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Fevaxyn Pentofel, suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 1 ml

More information

SEE ENCLOSED LEAFLET FOR FULL DETAILS SIEN INGESLOTE PAMFLET VIR VOLLE BESONDERHEDE

SEE ENCLOSED LEAFLET FOR FULL DETAILS SIEN INGESLOTE PAMFLET VIR VOLLE BESONDERHEDE SEE ENCLOSED LEAFLET FOR FULL DETAILS SIEN INGESLOTE PAMFLET VIR VOLLE BESONDERHEDE Alsystin 480 SC Registration No. L3810 (Act No. 36 of 1947) Registrasie Nr. L3810 (Wet Nr. 36 van 1947) A suspension

More information

Servus 25 EC. Reg. No. / Nr. L 7271 Act No. / Wet Nr. 36 of / van 1947 N-AR 0781

Servus 25 EC. Reg. No. / Nr. L 7271 Act No. / Wet Nr. 36 of / van 1947 N-AR 0781 Servus 25 EC Reg. No. / Nr. L 7271 Act No. / Wet Nr. 36 of / van 1947 N-AR 0781 An emulsifiable concentrate contact and stomach insecticide for the control of insects in crops as indicated. n Emulgeerbare

More information

July rd Issue

July rd Issue July 2012 2012 3rd Issue E-News sheds light on Midrand Estates in full colour and is distributed only in electronic format every alternate month. From pupils participating in the college spectacle So you

More information

PACKAGE INSERT. Each JURNISTA 4 mg extended-release tablet contains 4,36 mg and delivers 4 mg hydromorphone

PACKAGE INSERT. Each JURNISTA 4 mg extended-release tablet contains 4,36 mg and delivers 4 mg hydromorphone PACKAGE INSERT SCHEDULING STATUS Schedule 6 PROPRIETARY NAME AND DOSAGE FORM JURNISTA JURNISTA 4 mg extended-release tablets 8 mg extended-release tablets JURNISTA 16 mg extended-release tablets Contains

More information

RUNNER* 240 SC REG. NO. L7779 ACT NO 36 OF 1947 / WET NR 36 VAN 1947 CHEMICAL GROUP 18 CHEMIESE GROEP. Active Ingredient/Aktiewe Bestanddeel

RUNNER* 240 SC REG. NO. L7779 ACT NO 36 OF 1947 / WET NR 36 VAN 1947 CHEMICAL GROUP 18 CHEMIESE GROEP. Active Ingredient/Aktiewe Bestanddeel RUNNER* 240 SC REG. NO. L7779 ACT NO 36 OF 1947 / WET NR 36 VAN 1947 A SUSPENSION CONCENTRATE SELECTIVE CONTACT AND STOMACH INSECTICIDE (MOULT ACCELERATING COMPOUND) FOR THE CONTROL OF INSECT PESTS ON

More information

Kim Nolte DOCTOR PHILOSOPHIAE. In the. FACULTY OF HUMANITIES (Department of Biokinetics, Sport and Leisure Sciences) University of Pretoria

Kim Nolte DOCTOR PHILOSOPHIAE. In the. FACULTY OF HUMANITIES (Department of Biokinetics, Sport and Leisure Sciences) University of Pretoria EVALUATION OF RESISTANCE TRAINING EQUIPMENT USING THREE DIMENSIONAL MUSCULOSKELETAL MODELLING FOCUSING ON THE BIOMECHANICAL AND ANTHROPOMETRIC CONSIDERATIONS OF THE END- USER by Kim Nolte Submitted in

More information

DIE INVLOED VAN GRONDVERDIGTING OP DIE FOSFAATOPNAME DEUR TABAK. deur. Jasper Gestaphus Dreyer

DIE INVLOED VAN GRONDVERDIGTING OP DIE FOSFAATOPNAME DEUR TABAK. deur. Jasper Gestaphus Dreyer DIE INVLOED VAN GRONDVERDIGTING OP DIE FOSFAATOPNAME DEUR TABAK deur Jasper Gestaphus Dreyer Verhandeling voorgele ter gedeeltelike nakoming van die vereistes vir die graad MSc Grondkunde In die Fakulteit

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ERAVAC emulsion for injection for rabbits 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.5 ml contains:

More information

SHAKE THE BOTTLE WELL BEFORE USE. SKUD DIE BOTTEL GOED VOOR GEBRUIK. Reg. No. L 8590 Act/Wet No. 36 of/van 1947 N-AR 1225

SHAKE THE BOTTLE WELL BEFORE USE. SKUD DIE BOTTEL GOED VOOR GEBRUIK. Reg. No. L 8590 Act/Wet No. 36 of/van 1947 N-AR 1225 GEBRUIKSAANWYSINGS INGESLUIT Date formulated: VERWYS NA BESONDERHEDE Formuleringsdatum: GEDRUK OP HOUER/SAK DIRECTIONS FOR USE ENCLOSED Batch number: REFER TO DETAILS PRINTED Lotnommer: ON CONTAINER/BAG

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis IB Primo QX lyophilisate and solvent for suspension for chickens Nobilis IB Primo QX lyophilisate for suspension

More information

Reg. No. L6870 Act No. 36 of 1947 Reg. Nr. L6870 Wet Nr. 36 van fluzilazole (silicone triazole) g/l... flusilasool (silikoon triasool)

Reg. No. L6870 Act No. 36 of 1947 Reg. Nr. L6870 Wet Nr. 36 van fluzilazole (silicone triazole) g/l... flusilasool (silikoon triasool) NUSTAR 100 EW Reg. No. L6870 Act No. 36 of 1947 Reg. Nr. L6870 Wet Nr. 36 van 1947 Organic systemic fungicide (emulsion oil in water) for the control of scab and powdery mildew in apples and scab in pears.

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS [Version 8, 10/2012] Cevac MD HVT_2016-October-18 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cevac MD HVT suspension and solvent for suspension for injection

More information

Sien ingeslote voubiljet vir gebruiksaanwysings / See enclosed leaflet for directions for use

Sien ingeslote voubiljet vir gebruiksaanwysings / See enclosed leaflet for directions for use Sien ingeslote voubiljet vir gebruiksaanwysings / See enclosed leaflet for directions for use Constrictor 250 EC Reg. No. L10457 Wet / Act No. 36 van / of 1947 n Emulgeerbare konsentraat kontak, translaminêre

More information

ANNEX III LABELLING AND PACKAGE LEAFLET

ANNEX III LABELLING AND PACKAGE LEAFLET ANNEX III LABELLING AND PACKAGE LEAFLET 1 A. LABELLING 2 PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE PACKAGE Outer carton Multi-pack 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve

More information

Artemether 20mg/lumefantrine 120mg WHOPAR part 5 12/2011 Dispersible tablets (Novartis Pharma AG), MA069 LABELLING. Page 1 of 6

Artemether 20mg/lumefantrine 120mg WHOPAR part 5 12/2011 Dispersible tablets (Novartis Pharma AG), MA069 LABELLING. Page 1 of 6 LABELLING Page 1 of 6 PARTICULARS TO APPEAR ON THE OUTER PACKAGE CARTON OF UNIT PACK 1. NAME OF THE MEDICINAL PRODUCT Coartem Dispersible Artemether/Lumefantrine 2. STATEMENT OF ACTIVE SUBSTANCE(S) Artemether

More information

DOUBLESTAR 25 SL. Reg. No. L8884, Act No. 36 of 1947 Reg. Nr. L8884, Wet Nr. 36 van 1947

DOUBLESTAR 25 SL. Reg. No. L8884, Act No. 36 of 1947 Reg. Nr. L8884, Wet Nr. 36 van 1947 Main Panel For further information see attached pamphlet Vir verdere inligting sien aangehegte pamflet DOUBLESTAR 25 SL Reg. No. L8884, Act No. 36 of 1947 Reg. Nr. L8884, Wet Nr. 36 van 1947 A Soluble

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican DHPPi 2 -L multi Lyophilisate and suspension for suspension for injection. (for Bulgaria, Croatia, Cyprus,

More information

DEPRESSIE101. panic attacks - inside the brain TALKING about anxiety attacks. hanteer angstigheid beter snellers vir 'n paniekaanval

DEPRESSIE101. panic attacks - inside the brain TALKING about anxiety attacks. hanteer angstigheid beter snellers vir 'n paniekaanval 9 A P R I L 2 0 1 8 U I T G A W E 2 5 DEPRESSIE101 panic attacks - inside the brain TALKING about anxiety attacks hanteer angstigheid beter snellers vir 'n paniekaanval PANIC ATTACKS: INSIDE THE BRAIN

More information

A PLAY TECHNIQUE PROGRAMME FOR AUTISTIC CHILDREN IN MIDDLE CHILDHOOD

A PLAY TECHNIQUE PROGRAMME FOR AUTISTIC CHILDREN IN MIDDLE CHILDHOOD A PLAY TECHNIQUE PROGRAMME FOR AUTISTIC CHILDREN IN MIDDLE CHILDHOOD By CATHERINE ELIZABETH DAVIES SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE DOCTOR PHILOSOPHIAE IN THE FACULTY

More information

Leptospirosis has changed. Here's how to meet the new threat

Leptospirosis has changed. Here's how to meet the new threat Leptospirosis has changed. Here's how to meet the new threat Introducing Nobivac L 4 The UK s first tetravalent leptospirosis vaccine Serovars identified by positive MAT test results* from clinical submissions

More information